Toetal Solutions closed $1.02 million in its initial round of financing. Proceeds will enable Toetal to rapidly scale the development of its flagship product, the Ziptoe™ Hammertoe System.
Ziptoe is designed to enable foot and ankle surgeons to address rigid hammertoe deformities with a simple implant. Ziptoe features a proprietary deployable nitinol implant that comes sterile packed with all necessary disposable instrumentation to perform the procedure in any surgical setting.
"We've designed a product with physician input throughout every step of development. Our market research made it clear that the current product offerings for hammertoe fusion lacked efficacy or were too cumbersome to implant easily. Ziptoe's design meets the core tenants of proper bone fusion: Active Compression, Complete Stability, and Zero Rotation. We are excited to enter this next phase of product development and get this simple and easy-to-use product in the hands of foot and ankle surgeons," said Jeff O'Donnell, Jr., CEO, and Co-Founder of Toetal Solutions.
Runway Healthcare solely funded this financing and has a majority ownership position in the company. Toetal Solutions is Runway Healthcare's second portfolio company.
Source: Toetal Solutions, Inc.